|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net premiums and contract charges earned | |||||
| Net investment income | |||||
| Net investment (losses) | |||||
| Other income | |||||
| Total revenues | |||||
| Benefits, losses and expenses | |||||
| Benefits, claims and settlement expenses (Reserve remeasurement (gains)/losses $6.0, $1.6, $(1.6)) | |||||
| Interest credited | |||||
| Operating expenses | |||||
| DAC amortization expense | |||||
| Intangible asset amortization expense | |||||
| Interest expense | |||||
| Other expense - goodwill and intangible asset impairments | |||||
| Total benefits, losses and expenses | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Effect of adopting ASU 2018-12 | |||||
| Change in net unrealized investment gains (losses) on fixed maturity securities | |||||
| Change in net reserve remeasurements attributable to discount rates | |||||
| Change in net funded status of benefit plans | |||||
| Other comprehensive income | |||||
| Comprehensive income | |||||
| Net income per share | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average number of shares and equivalent shares | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...